This study was designed to determine whether reduction in platelet aggregate microembolization during the first 30 minutes of cardiopulmonary bypass is due to thrombocytopenia or to decreased ability of platelets to aggregate. The total volume of platelet aggregates induced in blood by adenosine diphosphate (ADP) was measured with a Coulter counter. The volume of platelets in blood was calculated by multiplying hemocytometry platelet counts by the mean platelet volume. Immediately before cardiopulmonary bypacrs, the total volume of aggregates induced in blood by ADP (2 +) was reduced when lterations in platelet function resulting from ex-A tracorporeal circulation of blood may contribute to hemostatic or thromboembolic complications following heart surgery.'-lo In addition, microembolization of platelet aggregates may cause pulmonary, cerebral and other complications which occur during cardiopulmonary bypass.ll-l9 In order to measure the quantity and size of microemboli in the blood of patients during cardiac operations, we have utilized an electronic particle size analyzer.*O Although some of these microemboli were fat globules, their concentration, by volume, was similar to that of platelet aggregates, which could be induced in oitro in the patients' arterial blood by adenosine diphosphate (ADP), and fell during the first 30 minutes on cardiopulmonary bypass.20 In view of the known effects of cardiopulmonary bypass on the concentration and on the reactivity of platelets,1-10J2-18 this reduction in microembolization probably resulted from alterations in the formation of platelet aggregates. The present study was designed to determine whether this apparent reduction in platelet aggregation dur- compared to normal donors because of (1) a slight fall in the volume of platelets, and (2) reduction in the percentage by volume of platelets which aggregated. After 30 minutes on bypass, the volume of both platelets and aggregates fell, but a greater percentage of platelets aggregated. This indicates that reduction of platelet aggregate formation during cardiopulmonary bypass is due to thrombocytopenia. It also suggests that anesthesia, surgical trauma and heparinization alter platelet reactivity more than cardiopulmonary bypass.
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ing cardiopulmonary bypass was due to thrombocytopenia or to a decreased ability of the platelets to aggregate.
Quantitative studies of platelet aggregation were performed on blood obtained from 20 adult patients during elective cardiac operations and from 20 normal blood donors. Nine of the patients had coronary artery bypass procedures, eight had mitral and/or aortic valve replacement, and three had combined coronary artery and valvular replacement surgery. Blood was obtained from the patients immediately before and 30 minutes after the onset of cardiopulmonary bypass. The sample before bypass was obtained after general anesthesia, median sternotomy and heparinization (300 units/kg sodium heparin, Upjohn, Kalarnazoo, Michigan). The bubble oxygenator (Variflo, Travenol Laboratories, Morton Grove, Illinois) was primed with 20 ml/kg of 5 percent dextrose in lactated Ringer's solution ( Travenol Laboratories). The arterial hemoglobin was determined spectrophotometrically (model 117 CO oximeter, Instrumentation Laboratories, Boston, Massachusetts). The details of the operative conditions have been described. 20 Blood drawn into plastic syringes was diluted in siliconized test tubes containing sodium citrate ( 9 : l by volume, Fisher Scientific, Fairlawn, New Jersey, ethylene-diamine tetraacetate (EDTA Vacutainer, Becton-Didtinson, Rutherford, New Jersey) or heparin ( 9 : l by volume, beef lung, Upjohn) to give find concentrations of 0.32 or 0.15 grams or 10 units per 100 ml, respectively. Platelet-rich plasma (PRP) was prepared by centrifugation of blood at W°C for ten minutes at 180 X g. Platelets were counted by phase hemocytometry in duplicate after dilution of blood drawn into EDTA in ammonium oxalate ( Unopette, Becton-Dickinson ) as described by Brecker and Cronkite. 21 The mean size of platelets in PRP was measured with an electronic particle size analyzer (model T, Counter Elec-tronics, Hialeah, Florida) using a 70 p aperture. The operation of the instrument and the analysis of the data have been described elsewhere.2"*'c:.z:3 Briefly, the instrument counts particles in 15 channels, each of which detects particles twice the volume of the previous channel. The volume of particles detected in each channel is calculated by multiplying the number counted by the mean size in cubic microns detected in the channel. PRP was diluted in a modified Eagles' solution (Isoton, Coulter Electronics) to a count of less than 2,000 per 0.1 ml. The mean volume of platelets was calculated by dividing the total volume of particles measured in the four channels detecting particles 3.0 to 23.7 p3 by the total number of particles counted. With this technique, the mean volume of platelets determined within 30 minutes of drawing the blood of the normal donors into sodium cihate (7.4 f 0.9 p3, mean 2 1 standard deviation) was significantly lower than similar measurements in PRP prepared from blood simultaneously drawn into EDTA (8.3 2 0.8 p3, P <.01 for paired "t" test). Spontaneous clumping of platelets precluded similar measurements of platelets in PRP prepared from heparinized blood. The total volume of platelets in blood which were available to aggregate, was calculated by multiplying the hemocytometry platelet count by the mean volume of platelets in citrated PRP.
Platelet aggregation was induced within 10 minutes after drawing the blood by adding 0.1 ml of phosphate-buffered ( p H 7.3) saline solution containing adenosine diphosphate (ADP, final concentrations: 0.2 or 2 pM, disodium salt, Sigma Chemical, St. Louis, Missouri) to 0.9 ml aliquots of blood in 12 x 75 mm sterile polystyrene test tubes (Falcon Plastics, Oxnard, California). The test tube was shaken continuously by hand at room temperature for 60 seconds, at which time 0.5 ml was transferred with a plastic 1 ml serologic pipette to 50 ml of dichlorodilluoromethane (Isotron) containing four drops of a hemolyzing solution (Zap-Isoton, Coulter Electronics). When hemolysis of the erythrocytes was grossly evident ( 3 to 5 seconds after dilution), particles were counted in nine different channels of the instniment as 2 ml of the continuously stirred suspension passed through a 200 p aperture. The mean size of particles detected in these nine channels, which is reported as the diameter of a sphere having a volume equal to the mean volume of particles counted in each channel, varied from 13 to 80 p.
The size distribution of platelet aggregates induced in aliquots of citrated blood by the two concentrations of ADP was determined in duplicate within 10 minutes of drawing the blood. Similar control measurements were made in citrated blood after addition of buffered saline solution containing no ADP. Data are reported as the total volume of particles 13 to 80 p in size measured by the instrument, as the percent by volome of those particles which were larger than 32 p, or as the mean and modal size. The mean platelet aggregate size was determined by dividing the total volume of particles 13 to 80p in sue by the number of particles detected within this size range. The modal size of the aggregates was the particle size in cubic microns detected by the channel which counted the largest volume of aggregates.
Measurements of platelet aggregates induced by ADP ( 2 The mean size of the patients' platelets before and after cardiopulmonary bypass was not different from that of the normal donors (Table 1 ) . However, the number and total volume of platelets in the patients' blood before bypass were significantly lower ( P <.01 for non-paired "t" test) than in the normal donors' blood and fell even further after 30 minutes on bypass. In 17 patients in whom arterial hemoglobin was also measured, the hemoglobin concentration ( grams/ 100 ml ) fell from 11.5 2 1.4 before bypass to 8.7 k 1.0 30 minutes after the onset of bypass. When compared to the measurements before bypass, the percentage of reduction in the platelet counts of these patients during bypass (61.4 k 14.9 percent) exceeded that of the hemoglobin concentration (75.8 + 6.5 percent, mean k standard deviation, P <.01 for paired "t" test ).
The relationship between the reduction in the total volume of platelets and in the total volume of platelet aggregates induced in blood during cardiopulmonary bypass is shown in Figure 1 . The total volume of aggregates induced in the blood of the normal donors by 2 and 0.2 pM ADP did not differ and represented 94 + 3 and 93 k 3 percent, respectively (mean + 1 standard error) of the total volume of platelets. In contrast, the total volume of aggregates induced by both doses of ADP in the patients' blood before bypass represented a significantly lower percentage of the total volume of platelets which were available to clump (79 + 3 and 69 k 4 percent respectively, P <.005) than was noted in the normal donors' blood. In addition, the total volume of aggregates induced by 0.2 pM ADP in the patients' blood was lower than that induced by 2 pM ( P <.005). After 30 minutes on cardiopulmonary bypass, there was a further reduction in the total volume of aggregates induced by 2 pM ADP; however, this was entirely due to thrombocytopenia, since the percentage of platelets ( 9 1 k 4 percent) which clumped to form aggregates 13 to 80 p in size actually increased ( P <.05 for paired "t" test). The total volume of aggregates induced by 0.2 pM ADP also fell in proportion to the reduction in the volume of platelets; however, the percentage, by volume of the platelets which formed aggregates (68 + 4 percent) remained unchanged when compared to the measurements before bypass.
In all studies, the total volume of particles measured in the control samples of blood treated with saline solution containing no ADP was markedly lower than measurements made after exposure to ADP (Fig 1 ) . However, the total volume of particles detected in the normal donors' control blood was greater than that detected in the patients' blood ( P <.05).
Although the total volume of platelet aggregates induced in the blood of the normal donors by the two concentrations of ADP did not differ, those formed in response to the higher concentration were larger (Table 2, Fig 2) . The size of the platelet aggregates induced in the blood of the patients before bypass did not differ from that of the normal donors (Table 2) . However, after 30 minutes on cardiopulmonary bypass, the aggregates were smaller ( Fig 3 ) . The thrombocytopenia which develops during cardiopulmonary bypass has been attributed to hemodilution with oxygenator prime, dilution with stored blood, and trauma resulting from contact of blood with foreign surfaces and gas in the oxygenator or cardiotomy return s y~t e m . ' -~,~~* '~ Experimental studies have demonstrated a partially reversible sequestration of platelets in the hepatic circulation during the initial few minutes on cardie pulmonary bypass.24 This has been attributed to trapping by the patients' microcirculation of platelet aggregates induced during the pro~edure'@'~*'~ and is consistent with the finding that a significant gradient of particulate microemboli across the oxygenator is noted only during the first ten minutes on cardiopulmonary bypass.20 In the present study, the thrombocytopenia which developed during bypass exceeded that which would have been expected from hemodilution, as reflected by the reduction in arterial hemoglobin. However, hemodilution accounted for most of the reduction in the platelet concentration.
Younger platelets, which are more active functionally and metabolically, are larger than older platelet^.^^.^^ The lack of change in the mean size of the patients' platelets during the development of thrombocytopenia while on cardiopulmonary bypass, suggests that the rate of removal of larger and smaller platelets was equal. Experimental error due to selection of a nonrepresentative population of platelets during preparation of PRP or to errors in the electronic measurement could also be responsible for this lack of change. The sizing of platelets with the model T is probably less precise than with a model B Coulter counter, which has narrower channel widths.27 However, the finding that the Most quantitative studies of in vitro platelet aggregation have utilized the turbidimetric meth0d.28-3~ Although the fraction of platelets which aggregate in plasma can be calculated from changes in the optical d e n~i t y ,~.~ these measurements cannot relate the mass of platelets in blood to the mass of aggregates formed either in vitro or in uivo. Assessment of platelet aggregation in vivo has therefore relied on either observation of the microcircul a t i~n~,~-~, -or on changes in the circulating platelet c~ncentration.~' The screen filtration press u r e~, l~-~~ and various platelet retention can measure platelet function in blood, but these techniques detect adhesive as well as aggregated platelets. In contrast, electronic particle measurements can quantitate the sue distribution of platelet aggregates formed in vitro and in v i v~.~~.~, ' O The present study demonstrates that in vivo factors which influence platelet aggregate formation can be quantified by relating electronic measurements of platelet aggregates induced in oitro to the total mass of platelets in blood. All but about 7 percent by volume of the platelets in the normal donors' blood formed aggregates 13 p or larger in response to both concentrations of ADP, with larger aggregates being formed as the concentration of ADP increased. In contrast, a greater percentage of platelets in the patients' blood before bypass did not form aggregates larger than 13 p and the total volume of aggregates induced by the two doses of ADP differed. Whether the remaining platelets failed to aggregate or formed aggregates smaller than 13 p is uncertain, since detection of leukocytes precludes electronic measurement of aggregates within this size range.= The cause of this alteration in the patients' platelets before bypass is not known, but anesthesia, surgical trauma and heparin have all been reported to alter platelet f~n c t i o n .~l ,~l~
The marked difference in the size of platelet aggregates induced by different concentrations of ADP (Fig 2 ) suggests that the propensity of platelets to aggregate might be characterized by changes in size independent of the total volume of aggregates formed under given experimental conditions. Similar alterations were noted in the size of platelet aggregates induced in vivo by ADP following pretreatment of rats with prostaglandin a potent inhibitor of platelet aggregation.& However, since the size of platelet aggregates induced by the same concentration of ADP varies directly with the initial platelet concentration,* alterations in platelet aggregate size may be due entirely to thrombocytopenia. The increase in the percentage of platelets which aggregated in re-sponse. to 2pM ADP during cardiopulmonary bypass, suggests that the reduction in the size as well as the total volume of the aggregates was due to thrombocytopenia rather than decreased platelet responsiveness to ADP.
When campared to the normal donors, the percentage of the patients' platelets which aggregated during cardiopulmonary bypass was reduced only in response to the lower concentration of ADP. However, a greater impairment of platelet aggregation was noted before bypass. This suggests that anesthesia, surgical trauma and/or heparinization had a more pronounced acute effect on the function of the circulating blood platelets than cardiopulmonary bypass. The discrepancy between these results and previous findings of reduced ADP-induced platelet aggregation during cardiopulmonary by pas^^.^ are difficult to explain in view of methodologic differences. The screen filtration pressure detects platelet aggregates indirectly as a result of increases in the resistance to flow of blood through a 20 p pore mesh filter. In addition to the size of platelet aggregates, this increased resistance to flow is also determined by the hemato~rit.~'.~~ In view of the hemodilution which occurs during cardiopulmonary bypass, the screen filtration pressure of blood may not detect alterations in platelet responsiveness to ADP even when corrected for changes in the platelet concentration. Turbidimetric measurements of platelet aggregation may be influenced by selection of a non-representative population of platelets during preparation of PRP. This, plus differences in species and in the concentration of ADP utilized, may account for the variance between turbidimetric measurements of platelet aggregation reported during cardiopulmonary bypass in pigs9 and the present study.
Although our investigation has been limited to determining the mechanism of the reduction in microembolization during cardiac surgery,20 the methods utilized may be applicable to the study of other clinical disorders in which platelet aggregation may be of importance. These include thrombosis and hemostasis as well as shock, trauma, and pulmonary embolism.26.31.38.m The electronic measurements of platelet aggregates induced in blood by ADP in vitro provide quantitative assessment of the mass of functioning platelets in blood. Although the platelet count provides the same relative information, the electronic measurements can be performed more rapidly and easily. When combined with an independent measurement of the number and mean volume df platelets in the blood, the electronic measurement of platelet aggregates induced in uitro can be used to assess the capacity of the platelets to aggregate. The present study demonstrates that this provides a unique means of correlating in vitro studies with measurements of platelet aggregates formed in uiuo in man.
